cardiology-summit-2019-scientifictracks

Page 28

March 25-26, 2019 | Amsterdam, Netherlands

CARDIOLOGY

AND CARDIAC NURSING

World Congress on

Cardiology Summit 2019

Journal of Cardiovascular Medicine and Therapeutics | Volume 3

OF EXCELLENCE

IN INTERNATIONAL

MEETINGS

YEARS

OBESE’S HEART: CLINICAL UTILITY OF CARDIAC ULTRASOUND AND

CONTRAST-ENHANCED ULTRASOUND IMAGING

Anca Simona Tau

and

Catalin Copaescu

Ponderas academic hospital, Romania

he rising prevalence of obesity is driving an increased focus on its role in promoting cardiovascular disease.

Morbid obesity (BMI >35 kg/m2) is the fastest growing category of obesity. Obesity, through complex and

not fully understood pathogenetic mechanisms, induces different structural and functional changes of both

ventricles, chronic systemic inflammation, the ‘inside to in’ model of atherosclerosis. The resultant syndrome is

known as obesity cardiomyopathy. The morbidly obese population now comprises a significant proportion of

patients referred for imaging. Transthoracic echocardiography applied in this specific patient population, obese

patients, can result in non-diagnostic images in up to 30% of patients and clinicians may reasonably be con-

cerned that such a test will be inconclusive, if feasible at all contrast-enhanced ultrasound imaging (CEUS) is ex-

pected to offer diagnostic imaging advantages in the morbidly obese patients. We run a study in a high-volume

Bariatric Surgery Centre of Excellence (Ponderas Academic Hospital), focusing on different cardiovascular adap-

tations to obesity, namely left ventricular function, by measuring ventricular volume and ejection fraction, stress

echocardography in patients with resting regional wall motion, better evaluation of pulmonary hipertension.

Finally, the role of weight loss and bariatric surgery is analysed. The utilization of Contrast-Enhanced Ultrasound

Imaging (CEUS), a non-invasive imaging modality, in technically difficult patients, obese patients respectively,

significantly improves endocardial visualization and impacts cardiac diagnosis, decreases variability of interpre-

tation, resource utilization, and patient management. CEUS is safe, cost-effective and avoids ionizing radiation.

CEUS reduces redundant downstream testing, resulting in a positive impact on patient management. CEUS has

a prominent role in the diagnosis and management of obese patients with cardiovascular disease The topics to

be covered include targeted drug delivery, tumor therapies, and remote catheter navigation. It will be shown

how iMRI enhances the safety and efficacy of these procedures.

Anca Simona Tau et al., J Cardiovasc Med Ther 2019, Volume 3

Anca Simona Tau has completed her PhD at the age of 31 years from “Carol Davila” University of Medicine Bucharest,

Romania. She is the head of department of cardiology and internal medicine, Ponderas Academic Hospital, Bucuresti,

Romania. She attended cardiac ultrasonography courses in Universitary Hospital Gasthuisberg- department of cardiol-

ogy, Leuven, Belgium. She graduated several courses in contrast enhanced echocardiography, accredited by ASE. She

participated as PI, co investigator and study coordinator in 7 international, multicentric, randomized, double-blind/open

label clinical trials. She has over 35 publications in national and interantional medical journals.

BIOGRAPHY